More than 11.5 million people this season have signed up for Obamacare, even as new President Donald Trump has vowed to repeal the law. » Read More
The average deductible of popular types of Obamacare plans jumped by 20 percent in 2017. » Read More
More than 8.8 million people so far have signed up for coverage from the federal Obamacare marketplace HealthCare.gov. » Read More
Johnson & Johnson also saw earnings beating and revenue matching estimates. The health-care giant also raised its yearly outlook.
Federal regulators are investigating blood-testing start-up Theranos over whether it misled investors.
There should be no continental U.S. travel restrictions for pregnant women due to Zika concern, NIH's Dr. Anthony Fauci tells CNBC.
AstraZeneca has held internal talks about a bid for cancer treatment maker Medivation but has yet to make a formal offer, the Sunday Times reported.
CEO Elizabeth Holmes says Theranos is rebuilding its laboratory from scratch "so that we can ensure it never happens again."
UnitedHealth's earnings set the tone for the health sector, and this quarterly report may be even more of a bellwether than usual.
Bill Miller said the troubled pharmaceutical company should be worth about double its current trading price.
News of potential sanctions against blood-testing company Theranos was not surprising, business school professors told CNBC.
U.S. health officials have concluded that infection with the Zika virus in pregnant women is a cause of the birth defect microcephaly.
Countries around the world have very different — and sometimes confusing — standards for moderate or "low-risk" alcohol consumption.
The new primary care payment model will affect up to 25 million patients, and 20,000 doctors by tying patient outcomes to Medicare payments.
A lot of focus has been placed on how virtual reality (VR) technology will transform the gaming industry, but it has many real-world uses.
When it comes to health and fitness, is the tech that’s meant to help you, actually hurting your progress?
The fast pace of employment growth will create serious wage pressures and, eventually, higher inflation, says Gad Levanon of The Conference Board.
Chinese researchers have reported successfully adding HIV-resistant mutations into human embryos, according to an article in Nature on Friday.
Under-fire drug giant Valeant Pharmaceuticals International won't put Bausch & Lomb on the block, investor Bill Ackman told CNBC.
Get the best of CNBC in your inbox